Search results
Results From The WOW.Com Content Network
Viatris Pharmaceutical Plant in Istanbul. 27 may 2023. The company produces and sells a variety of medicines, with 1,400 approved therapeutic molecules in its portfolio. [ 30 ] It owns brands (like Viagra , Xanax , Lipitor ), [ 6 ] [ 31 ] generics , including branded and complex generics, biosimilars , [ 32 ] [ 33 ] and over-the-counter (OTC ...
Alcon offices in Johns Creek, Georgia. Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people.
Mylan Pharmaceuticals was founded as a drug distributor in 1961 by Milan Puskar and Don Panoz. [12] In 1966, the company began manufacturing penicillin G tablets as well as vitamins and other dietary supplements.
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
In 2001 the company acquired Biochem Canada. [9] Shire's next acquisition didn't come until 2005 when it acquired Transkaryotic Therapeutics [10] and two years later – in 2007 – New River Pharmaceuticals Inc, for a then company record of $2.6 billion. [11]
William H. Rorer, Inc was an American multinational pharmaceutical company headquartered in Fort Washington, Pennsylvania. It was founded in 1910 by William H. Rorer, a Pennsylvania pharmacist. [1] The business operated as a small concern, primarily selling pain relievers manufactured elsewhere.
Icos chairman, chief executive, and president Paul Clark received "a 'golden parachute' worth $23.2 million in severance pay, cashed-out stock options, restricted stock awards and other bonuses for retention and closing the deal." [68] Nine senior Icos executives received similar packages, each worth more than $1 million. [68]
Roivant's technology portfolio also includes Lokavant, which integrates clinical trial data to identify and mitigate risks in pharmaceutical development. [7] [9] In 2017, Roivant partnered with the private equity arm of Chinese state-owned CITIC Group to form Sinovant.